Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01063478 · ClinicalTrials.gov registry record · Phase 1
Dose Escalation Study of RAD001 in Combination w/Chemotherapy & Radiation in Patients With NSCLC
A Phase 1 study, sponsored by University of Chicago.
- Terminated
- Registry status
- Phase 1
- Development phase
- 3
- Enrollment target
NCT01063478: Clinical Trial Phase 1 study, sponsored by University of Chicago.
NCT01063478 is a Phase 1 study that was terminated before completion, run by University of Chicago. The registered enrollment target is 3 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01063478, a Phase 1 study, was terminated before completion, sponsored by University of Chicago.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 3 participants
- Enrollment target
Study Summary
The purpose of this study is to understand the effects (good and/or bad) of the addition of RAD001 to standard radiation and chemotherapy (cisplatin and pemetrexed) for patients with non-small cell lung cancer.
Interventions
- DRUG RAD001 (in addition to standard radiation and chemotherapy)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2010-02 |
| Est. Completion | 2012-01 |
| Phase | Phase 1 |
Why NCT01063478 stopped before completion
NCT01063478 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 3 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (95% lower).
The record links to 0 conditions, and to 1 intervention - of which RAD001 (in addition to standard radiation and chemotherapy) is the first listed.
NCT01063478 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01063478 about?
NCT01063478 is a clinical study titled "Dose Escalation Study of RAD001 in Combination w/Chemotherapy & Radiation in Patients With NSCLC". The purpose of this study is to understand the effects (good and/or bad) of the addition of RAD001 to standard radiation and chemotherapy (cisplatin and pemetrexed) for patients with non-small cell lung cancer.
What is the current status of trial NCT01063478?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 3 participants. The study started on 2010-02. Estimated completion is 2012-01.
What interventions are being tested in trial NCT01063478?
The interventions under investigation include: RAD001 (in addition to standard radiation and chemotherapy) (DRUG).
Who is sponsoring clinical trial NCT01063478?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01063478's enrollment target sits among peer trials
3 1999th of 2000 higher than 1 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia